JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2009; 109:1111-1116
© 2009 International Anesthesia Research Society
doi: 10.1213/ANE.0b013e3181b5a2a7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jinks, S. L.
Right arrow Articles by Antognini, J. F.
PubMed
Right arrow Articles by Jinks, S. L.
Right arrow Articles by Antognini, J. F.
Related Collections
Right arrow Mechanisms
Right arrow Preclinical Pharmacology
Right arrow Pharmacology


ANESTHETIC PHARMACOLOGY

Nitrous Oxide-Induced Analgesia Does Not Influence Nitrous Oxide's Immobilizing Requirements

Steven L. Jinks, PhD*, Earl Carstens, PhD{dagger}, and Joseph F. Antognini, MD*{dagger}

From the Departments of *Anesthesiology and Pain Medicine, and {dagger}Neurobiology, Physiology and Behavior, University of California, Davis, Davis, California 95616.

Address correspondence and reprint requests to Steven L. Jinks, PhD, Department of Anesthesiology and Pain Medicine, TB-170, University of California School of Medicine, Davis, CA 95616. Address e-mail to sljinks{at}ucdavis.edu.

BACKGROUND: Nitrous oxide (N2O) acts on supraspinal noradrenergic neurons to produce analgesia, but it is unclear if analgesia contributes to N2O's immobilizing effects. We tested the hypothesis that N2O minimum alveolar anesthetic concentration (MAC) is unchanged after selective ablation of supraspinal noradrenergic neurons, or in naïve animals at N2O exposure timepoints when analgesia is absent.

METHODS: We determined tailflick latency (TFL) and hindpaw withdrawal latency (HPL) under 70% N2O, N2O MAC, and isoflurane MAC before and after intracerebroventricular injections of anti-dopamine-β hydroxylase conjugated to saporin (SAP-DBH; n = 7), or a control antibody conjugated to saporin (n = 5). In a separate group of naive rats (n = 8), N2O MAC was determined at 25–45 min after initiation of N2O exposure (during peak analgesia) and again at 120–140 min (after TFL and HPL returned to baseline).

RESULTS: After 30 min of N2O exposure, TFL and HPL increased significantly but declined back to baseline within 120 min. N2O did not produce analgesia in rats that received SAP-DBH. However, N2O and isoflurane MAC were not significantly different between SAP-DBH and control-injected animals (Mean ± sd for N2O: 1.7 ± 0.1 atm vs 1.7 ± 0.2 atm; isofurane: 1.6 ± 0.2% vs 1.7 ± 0.2%). In naïve animals, N2O MAC was not different at the 30 min period compared with the 120 min period (1.8 ± 0.1 atm vs 1.8 ± 0.2 atm).

CONCLUSIONS: Destroying brainstem noradrenergic neurons or prolonged exposure to N2O removes its analgesic effects, but does not change MAC. The immobilizing mechanism of N2O is independent from its analgesic effects.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2009 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2009 by the International Anesthesia Research Society.